Literature DB >> 18390634

Minimum clinically important improvement for the incremental shuttle walking test.

S J Singh1, P W Jones, R Evans, M D L Morgan.   

Abstract

BACKGROUND: The incremental shuttle walking test (ISWT) is used to assess exercise capacity in patients with chronic obstructive pulmonary disease (COPD) and is employed as an outcome measure for pulmonary rehabilitation. This study was designed to establish the minimum clinically important difference for the ISWT.
METHODS: 372 patients (205 men) performed an ISWT before and after a 7-week outpatient pulmonary rehabilitation programme. After completing the course, subjects were asked to identify, from a 5-point Likert scale, the perceived change in their exercise performance immediately upon completion of the ISWT. The scale ranged from "better" to "worse".
RESULTS: The mean (SD) age was 69.4 (8.4) years, forced expiratory volume in 1 s (FEV(1)) 1.06 (0.53) l and FEV(1)/forced vital capacity (FVC) ratio 50.8 (18.1)%. The baseline shuttle walking test distance was 168.5 (114.6) m which increased to 234.7 (125.3) m after rehabilitation (mean difference 65.9 m (95% CI 58.9 to 72.9)). In subjects who felt their exercise tolerance was "slightly better" the mean improvement was 47.5 m (95% CI 38.6 to 56.5) compared with 78.7 m (95% CI 70.5 to 86.9) in those who reported that their exercise tolerance was "better" and 18.0 m (95% CI 4.5 to 31.5) in those who felt their exercise tolerance was "about the same".
CONCLUSION: Two levels of improvement were identified. The minimum clinically important improvement for the ISWT is 47.5 m. In addition, patients were able to distinguish an additional benefit at 78.7 m.

Entities:  

Mesh:

Year:  2008        PMID: 18390634     DOI: 10.1136/thx.2007.081208

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  55 in total

1.  The effects of supervised exercise training 12-24 months after bariatric surgery on physical function and body composition: a randomised controlled trial.

Authors:  L Y Herring; C Stevinson; P Carter; S J H Biddle; D Bowrey; C Sutton; M J Davies
Journal:  Int J Obes (Lond)       Date:  2017-03-06       Impact factor: 5.095

2.  Inspiratory muscle training in patients with chronic obstructive pulmonary disease: the state of the evidence.

Authors:  Michael J Shoemaker; Sarah Donker; Ashley Lapoe
Journal:  Cardiopulm Phys Ther J       Date:  2009-09

Review 3.  Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?

Authors:  Matthew C Miles; James F Donohue; Jill A Ohar
Journal:  Drugs       Date:  2012-02-12       Impact factor: 9.546

4.  Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial.

Authors:  Gülşah Barğı; Meral Boşnak Güçlü; Zeynep Arıbaş; Şahika Zeynep Akı; Gülsan Türköz Sucak
Journal:  Support Care Cancer       Date:  2015-07-02       Impact factor: 3.603

Review 5.  Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Raolat M Abdulai; Tina Jellesmark Jensen; Naimish R Patel; Michael I Polkey; Paul Jansson; Bartolomé R Celli; Stephen I Rennard
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

6.  Pulmonary Rehabilitation Reduces Emergency Admission and Hospitalization Rates of Patients with Chronic Respiratory Diseases.

Authors:  İpek Özmen; Elif Yıldırım; Murat Öztürk; Birsen Ocaklı; Reyhan Yıldız; Rüya Aydın; Meral Karakış; Özgür Yılmaz; Emine Aksoy
Journal:  Turk Thorac J       Date:  2018-09-13

Review 7.  Impact of bronchodilator therapy on exercise tolerance in COPD.

Authors:  B Aguilaniu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

Review 8.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

9.  Efficacy of a multidisciplinary pulmonary rehabilitation outpatient program on exacerbations in overweight and obese patients with asthma.

Authors:  Ipek Candemir; Pinar Ergun; Dicle Kaymaz
Journal:  Wien Klin Wochenschr       Date:  2017-09-11       Impact factor: 1.704

10.  Oxygen consumption, shuttle walking test and the evaluation of lung resection.

Authors:  Roberto P Benzo; Frank C Sciurba
Journal:  Respiration       Date:  2009-08-11       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.